BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
about
PALB2: research reaching to clinical outcomes for women with breast cancerAssociation between the BRCA2 rs144848 polymorphism and cancer susceptibility: a meta-analysis.Expression Quantitative Trait loci (QTL) in tumor adjacent normal breast tissue and breast tumor tissue.Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers.Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study.Germline genetic variants in men with prostate cancer and one or more additional cancers.Differential analysis of mutations in the Jewish population and their implications for diseases.A Review of Whole-Exome Sequencing Efforts Toward Hereditary Breast Cancer Susceptibility Gene Discovery.BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer.Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS study.Genomic Subtypes of Non-invasive Bladder Cancer with Distinct Metabolic Profile and Female Gender Bias in KDM6A Mutation Frequency.A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors.Spectrum of genetic variants of BRCA1 and BRCA2 in a German single center study.Immunotherapy for Prostate Cancer: Where We Are Headed.Double Heterozygosity for BRCA1 Pathogenic Variant and BRCA2 Polymorphic Stop Codon K3326X: A Case Report in a Southern Italian Family.Response: Table 1Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen ConcentrationsWhole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma
P2860
Q26751309-F50A5334-E2D4-46F3-B87F-5F896DC16850Q33889402-EDD53F93-AD7A-4D43-85B7-343FF9969DFCQ36267818-88EF4B30-D1F2-4BE7-ABA5-3308EAF4C10BQ37179254-ED17B826-AAB5-42D1-A61B-81BCC778E234Q37578078-0D2A34E1-73E5-4B20-8F30-4B34E5F841D8Q38685850-13BE3B4C-E1D2-4F2B-803A-51A9EC90E96BQ38705089-36203817-E497-4FC8-BAED-7397765888C9Q38787257-E23A03D6-F339-4E64-AE47-6E4C3C7AB840Q38844517-4FD30FFC-C7DE-4A23-BAA5-3B39ABD0F169Q38914005-EADC294D-0405-44C5-8852-CEAD465467BCQ41691570-EDA31818-9ECD-400D-8847-19A53D0298F2Q47404654-283ACA1F-0489-4431-A6AE-A55B72F0CCB7Q47577143-5472A72A-08C7-4643-BD9A-B80C55C1608FQ48096924-A3A74E82-A227-4125-81ED-278E58B29715Q48176349-916358C7-CB0C-4333-AB51-23ECD411B960Q49332955-46BF29CD-B1BE-4B14-9C37-5836CE6078FBQ57269829-DBAA78E6-CC39-4785-A6E2-936A477FCB3CQ58122651-E214BC40-F23F-4DA5-894D-8916E6150F58Q58766079-8DDA0BB4-D0DB-4F4B-AF6E-6111C611DB8F
P2860
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
@en
BRCA2 Polymorphic Stop Codon K ...... Prostate, and Ovarian Cancers.
@nl
type
label
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
@en
BRCA2 Polymorphic Stop Codon K ...... Prostate, and Ovarian Cancers.
@nl
prefLabel
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
@en
BRCA2 Polymorphic Stop Codon K ...... Prostate, and Ovarian Cancers.
@nl
P2093
P2860
P50
P356
P1476
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
@en
P2093
Alice S Whittermore
Alicia Beeghly-Fadiel
Allen Jensen
Andrea Tesoriero
Andrew Berchuck
Andrew K Godwin
Anita Collavoli
Anna Öfverholm
P2860
P356
10.1093/JNCI/DJV315
P407
P50
P577
2015-11-19T00:00:00Z